Log In
BCIQ
Print this Print this
 

Mencevax (Mencevax ACWY)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionUnconjugated polysaccharide vaccine against Neisseria meningitidis serogroups A, C, Y and W-135
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationMeningitis
Indication DetailsPrevent meningitis caused by the four serogroups of Neisseria meningitidis (A, C, W and Y)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$130.2M

$130.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/22/2015

$130.2M

$130.2M

0

Get a free BioCentury trial today